WaveMan
WaveMan · Company
OXBR · Oxbridge Re Holdings Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

OXBR Oxbridge RE (OXBR) Insider Trading, Ownership & Congress Trades

Insurance · Fire, marine & casualty insurance · CIK 0001584831
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
10
13F, latest reported quarter

Oxbridge RE insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for OXBRIDGE RE HOLDINGS Ltd in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
MARTIN ALLAN S.
SELL
2025-09-19 SECtraded 2025-09-16
4,328
$10.6K
-69.2%
Context
  • 34 earlier Form 4 trades (code P or S) here by this insider (4 buys, 30 sales), the last on Aug 27, 2025.
  • -2.1% median (+1.7% mean) 90-day return after 4 previous buys.
  • The trade is 2.0% of the 216,803 shares held after it.
  • No other insider sold within 30 days.
  • 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MARTIN ALLAN S. sold about $10.6K of OXBR on Sep 16, 2025; 10 funds added in the latest 13F quarter.
MARTIN ALLAN S.
SELL
2025-08-29 SECtraded 2025-08-27
3,449
$8.2K
-65.0%
Context
  • 32 earlier Form 4 trades (code P or S) here by this insider (4 buys, 28 sales), the last on Jul 24, 2025.
  • -2.1% median (+1.7% mean) 90-day return after 4 previous buys.
  • The trade is 1.5% of the 227,682 shares held after it.
  • No other insider sold within 30 days.
  • 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MARTIN ALLAN S. sold about $8.2K of OXBR on Aug 27, 2025; 10 funds added in the latest 13F quarter.
MARTIN ALLAN S.
SELL
2025-08-29 SECtraded 2025-08-27
6,551
$15.6K
-65.0%
Context
  • 32 earlier Form 4 trades (code P or S) here by this insider (4 buys, 28 sales), the last on Jul 24, 2025.
  • -2.1% median (+1.7% mean) 90-day return after 4 previous buys.
  • The trade is 3.0% of the 221,131 shares held after it.
  • No other insider sold within 30 days.
  • 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MARTIN ALLAN S. sold about $15.6K of OXBR on Aug 27, 2025; 10 funds added in the latest 13F quarter.
MARTIN ALLAN S.
SELL
2025-07-24 SEC
2,000
$4.9K
-66.2%
Context
  • 31 earlier Form 4 trades (code P or S) here by this insider (4 buys, 27 sales), the last on Jul 23, 2025.
  • -2.1% median (+1.7% mean) 90-day return after 4 previous buys.
  • The trade is 0.9% of the 231,131 shares held after it.
  • No other insider sold within 30 days.
  • 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MARTIN ALLAN S. sold about $4.9K of OXBR on Jul 24, 2025; 10 funds added in the latest 13F quarter.
MARTIN ALLAN S.
SELL
2025-07-24 SECtraded 2025-07-23
2,000
$4.8K
-66.2%
Context
  • 30 earlier Form 4 trades (code P or S) here by this insider (4 buys, 26 sales), the last on Jul 22, 2025.
  • -2.1% median (+1.7% mean) 90-day return after 4 previous buys.
  • The trade is 0.9% of the 233,131 shares held after it.
  • No other insider sold within 30 days.
  • 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MARTIN ALLAN S. sold about $4.8K of OXBR on Jul 23, 2025; 10 funds added in the latest 13F quarter.
38 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 33 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
10 funds bought in last quarter
below 92% of Insurance
Revenue
+372.0% year over year
more than 98% of Insurance
Margin
-80.7% net margin
below 94% of Insurance
Buybacks
no share repurchases reported
Short interest
0.2% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 91% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch OXBR

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-57.7%12M
-58%-37%-16%+5%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns OXBR: institutional holders (13F)

13F holdings, latest reported quarter
GEODE CAPITAL MANAGEMENT, LLC
159,475 sh
$164.3K
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
100,000 sh
$127.0K
LPL Financial LLC
100,673 sh
$103.7K
J.W. COLE ADVISORS, INC.
75,305 sh
$77.6K
Henrickson Nauta Wealth Advisors, Inc.
67,780 sh
$69.8K

Congress trades in OXBR

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

OXBR planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

OXBR mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD EXTENDED MARKET INDEX FUND
$60.2K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Madhu
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$502.4K
$433.8K
$334.2K
-29%
n/a
2024
$657.4K
$767.4K
$446.4K
+121%
n/a
2023
$400.1K
$346.2K
$259.6K
-41%
n/a
2022
$290.3K
-$213.2K
$167.3K
-36%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 10 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

OXBR financials

Revenue growth
+372.0%
XBRL, annual
Net margin
-80.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.8M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+4.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$489.0K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+2.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+0.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no debt line filed
FCF yield
+8.7%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$2.6M$546.0K-$7.0M$850.0K
Net income-$2.1M-$2.8M-$9.9M-$1.8M
EPS (diluted)-0.28-0.45-1.69-0.31
Operating cash flow-$1.3M-$284.0K-$1.3M-$829.0K
Cash$268.0K$2.1M$495.0K$1.2M
SEC XBRL, fiscal years, as known on 2026-10-28

OXBR Stock Sonar score 4/7 axes

Find similar shapesCompare

OXBR ranks highest on growth (98th percentile) and risk and compliance (96th), and lowest on institutional and government (8th), among Insurance peers.

Profitability
23
Inputs
  • Return on equity+2.2% · 14 pct, sector of 116
  • Return on assets+0.9% · 31 pct, sector of 122
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Growth
98
Inputs
  • Revenue growth, YoY+372.0% · 98 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
8
Inputs
  • Funds adding, latest quarter10 · 8 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
96
Inputs
  • Short interest, % of float+0.2% · 93 pct, sector of 138
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+0.5% · 99 pct, sector of 110
3 not measured: Financial health, Insider conviction, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies